Charles River Laboratories International, Inc.
| New York Stock Exchange: CRL
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. The company operates its business through two reporting segments: Research Models and Services and Preclinical Services. The Research Models and Services segment supplies research models to the drug development industry. It also provides a variety of related services that are designed to assist its clients in supporting the use of research models in drug discovery and development. The Research Models and Services segment comprises of Research Models, Research Model Services, and Endotoxin and Microbial Detection. The Preclinical Services segment provides services that enable its clients to outsource their critical, regulatory-required safety assessment and related drug development activities. Charles River Laboratories was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.